Cover Image
市場調查報告書

癌症檢驗的美國市場:2015年∼2019年

Cancer Testing Market in the US 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 345481
出版日期 內容資訊 英文 55 Pages
訂單完成後即時交付
價格
Back to Top
癌症檢驗的美國市場:2015年∼2019年 Cancer Testing Market in the US 2015-2019
出版日期: 2015年11月18日 內容資訊: 英文 55 Pages
簡介

美國的癌症診斷的市場在預測期間內,預計以超越9%的年複合成長率發展。醫療制度的變化帶給市場成長大幅影響。

本報告提供美國的癌症檢驗的市場相關調查、市場概要、主要供應商的提供產品範例、市場整體及各技術類型 (傳統檢驗、遺傳基因檢驗)、癌症種類的主要趨勢及市場規模的變化與預測、市場成長的各種影響因素分析、競爭環境與市場佔有率、主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 調查範圍

  • 市場概要
  • 主要供應商的提供產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

  • 焦點

第5章 美國的醫療改革

  • 美國的醫療改革對癌症檢驗產業的影響

第6章 償付和保險覆蓋範圍:概要

  • 目前方案:診斷檢驗的有效性確認
  • 美國的償付結構
  • 償付政策的課題

第7章 市場形勢

  • 市場概要
  • 市場規模、預測
  • 波特的五力分析

第8章 市場分析:各技術

  • 乳癌
  • 直腸癌
  • 前列腺癌
  • 其他

第9章 市場成長的促進要素

第10章 市場推進因素的影響

第11章 市場課題

第12章 市場推進因素、課題的影響

第13章 市場趨勢

第14章 供應商環境

  • 競爭模式
  • 市場佔有率分析
  • 其他的有力供應商

第15章 主要供應商分析

  • Abbott Diagnostics
  • Agilent Technologies
  • Beckman Coulter
  • Roche Diagnostics

第16章 附錄

第17章 關於Technavio

圖表

目錄
Product Code: IRTNTR7931

Covering: Market size and forecast of the cancer testing market in the US and segmentation by technique, including genetic testing and conventional testing. The report discusses the major drivers influencing market growth and the challenges faced by the vendors and the market as a whole. The top vendors evaluated in the report are Abbott Diagnostics, Agilent Technologies, Beckman Coulter, and Roche Diagnostics.

Market outlook of the cancer testing market in the US

The market in the US is experiencing a lot of transformation in healthcare coverage, which have led to increased accessibility to healthcare, and thereby facilitating early diagnosis, preventive medicine, and personalized medicine. The increase in genetic testing for cancer by end-user segments such as hospitals, diagnostic laboratories, and academics and research institutes are expected to propel the growth of the market.

Technavio predicts the cancer diagnostics market in the US to grow at a steady rate, posting a CAGR of over 9% during the forecast period.

Changes in healthcare system is one of the major drivers influencing the market growth. The number of the US citizens covered under healthcare insurance has increased tremendously and today about 19 million citizens in the US have insurance coverage. Also, big companies provide healthcare insurance policies to their employees, which will support the growth of the market.

Segmentation of the cancer testing market in the US by technique

  • Genetic testing
  • Conventional testing

The year 2014 saw the dominance of conventional testing segment, accounting for a market share of more than 76% and this segment is predicted to remain at the top through 2019.

Both genetic testing and conventional testing techniques are used for testing various types of cancer, including breast cancer, colorectal cancer, prostate cancer, and others.

Competitive landscape and key vendors

The cancer testing market in the US marks the existence of many small and medium sized vendors offering a diversified product portfolio. Large corporations are acquiring small and medium-sized manufacturers to enhance their product portfolio, which is adding to the competition.

Top vendors in this market are -

  • Abbott Diagnostics
  • Agilent Technologies
  • Beckman Coulter
  • Roche Diagnostics

Other prominent vendors included in this report are Affymetrix, Bio-Rad Laboratories, Cardinal Health, Cytyc, Fujirebio Diagnostics, Johnson & Johnson, Pathway Genomics, QIAGEN, Quest Diagnostics, Quidel, and Rosetta Genomics.

Growth drivers, challenges, and upcoming trends: Cancer testing

Technavios market research analysts highlight the use of mass spectrometer, an extremely sophisticated instrumentation technology, which provide accurate results with infinitesimal amounts of material and does not even require specially purified samples.

This report provides a number of factors contributing to the adoption, limitations, and opportunities of the cancer testing market in the US. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019
  • What are the key factors driving the cancer testing market in the US
  • What are the key market trends impacting the growth of the cancer testing market in the US
  • What are the challenges to market growth
  • Who are the key vendors in the cancer testing market in the US
  • What are the market opportunities and threats faced by the vendors in the cancer testing market in the US
  • What are the key outcomes of the five forces analysis of the cancer testing market in the US

Technavio also offers customization on reports based on specific client requirement.

Related reports

  • Global Cervical Cancer Market 2015-2019
  • Global Cancer Pain Therapeutics Market 2015-2019
  • Global Head and Neck Cancer Diagnostics Market 2015-2019
  • Global Gynecological Cancers Market 2014-2018
  • Global Cervical Cancer Diagnostic Tests Market 2014-2018

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: US healthcare reform

  • Impact of US healthcare reform on cancer testing industry

PART 06: Reimbursement and coverage: an overview

  • Current scenario: validating diagnostic tests
  • Reimbursement structure in the US
  • Prevailing issues of reimbursement policies

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by technique

  • Breast cancer
  • Colorectal cancer
  • Prostate cancer
  • Other

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 15: Key vendor analysis

  • Abbott Diagnostics
  • Agilent Technologies
  • Beckman Coulter
  • Roche Diagnostics

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Comparison of US healthcare infrastructure before and after reform
  • Exhibit 03: Reimbursement perspectives of healthcare entities
  • Exhibit 04: Cancer testing market in the US
  • Exhibit 05: Cancer testing market in the US 2014-2019 ($ billions)
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Segmentation of cancer testing market in the US by techniques
  • Exhibit 08: Segmentation of cancer testing market in the US by techniques 2014
  • Exhibit 09: Segmentation of cancer testing market in the US by techniques 2019
  • Exhibit 10: Segmentation of cancer testing market in the US by cancer type techniques 2014-2019
  • Exhibit 11: Breast cancer testing market in the US 2014-2019 ($ billions)
  • Exhibit 12: Colorectal cancer testing market in the US 2014-2019 ($ billions)
  • Exhibit 13: Prostate cancer testing market in the US 2014-2019 ($ billions)
  • Exhibit 14: Other cancers testing market in the US 2014-2019 ($ billions)
  • Exhibit 15: Segmentation of cancer testing market in the US by cancer type 2014
  • Exhibit 16: Impact of drivers
  • Exhibit 17: Impact of drivers and challenges
  • Exhibit 18: Abbott Diagnostic: Key takeaways
  • Exhibit 19: Agilent Technologies: Key takeaways
  • Exhibit 20: Beckman Coulter: Key takeaways
  • Exhibit 21: Roche Diagnostics: Key takeaways
  • Exhibit 22: Abbott Diagnostics: Key business offerings
  • Exhibit 23: Agilent Technologies: Business segmentation 2014 by revenue
  • Exhibit 24: Agilent Technologies: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 25: Agilent Technologies: Geographical segmentation by revenue 2014
  • Exhibit 26: Beckman Coulter: Business segmentation
Back to Top